H-1B Visa fee increase to Trump’s rates: Top reasons for Fiis’s outflow in the Indian stock market

Indian stock market: After escalation in trade speeches after Trump’s 100% pharmaceutical rate, the most important measures of the Indian stock market ended for the seventh direct session Friday last week. In these seven consecutive sessions, the Nifty 50 index moved from 25,423 to 24,654, and baptized more than 750 points or about 3% in this sharp sale. Despite strong support from the purchase of the DIIS, FII’s net sellers remained by selling Indian shares worth £ 30,141.68 in the cash segment this month. As two more sessions are left in September 2025, FIIs are expected to remain net sellers in the cash segment for the third consecutive month. In July and August this year, they sold Indian shares in cash worth £ 47,666.68 and £ 46,902.92 crore. According to stock market experts, escalation in the trade war following the imposition of 25% Trump’s rates on India, followed by an additional 25% tariff for importing crude oil from Russia and the H-1B visa money raised to $ 1,00,000 for fresh applicants, FIIs finds no reason to sell in the Indian stock market. However, they said that declining Indian National Rupee (INR) against the US Dollar (USD) is also an important reason for the continued sale of Dalal street list. They said the stronger US dollar against the Indian Rupee will detect the returns of the FIIs of the Indian stock market. The main reasons for Fiis’s record outflow that highlight the main reasons that filled the outflow of the Indian stock market, Khushi Moutry, research analyst at Bonanza, said: “Foreign Institutional Investors (FIIs) and Foreign Institutional Investors (FIIs) sell Indian stocks and new rates for Trump markets, the H-1B Visa fee steps) Earnings, Rupee value reductions and the dislike of the global risks and export-driven segments (textile, jewelry, chemicals) have the sharpest pressure due to direct policy risk and the broader market, including the factors selling India! Jasuja, head of shares and founding partner at Centricity WealthTech, said: “An important challenge is a subdued income. Rates on selected goods have risen to 50%, with a new announcement imposing 100% rates on pharmaceutical brands, which is likely to further disrupt the FIIs by adding existing economic uncertainty, “Sachin Jasuja added. USA, it intends to use all levers-including rates and visa constraints-to India, especially on Russian oil imports. The rupee falls, and that the dollar is the returns of the dollar, which has the foreign investors, and as a result of the domestic ownership of the dollar. not.